G. Bellis, C. Dehillotte, and L. Lemonnier, Registre français de la mucoviscidoseBilan des données, 2016.

E. J. Grant, A. Brenner, H. Sugiyama, R. Sakata, A. Sadakane et al., Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors, Radiat Res, pp.1958-2009, 2017.

W. Hsu, D. L. Preston, M. Soda, H. Sugiyama, S. Funamoto et al., The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors, Radiat Res, vol.179, issue.3, pp.361-82, 2013.

M. S. Pearce, J. A. Salotti, M. P. Little, K. Mchugh, C. Lee et al., Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study, Lancet Lond Engl, vol.380, issue.9840, pp.499-505, 2012.

J. D. Mathews, A. V. Forsythe, Z. Brady, M. W. Butler, S. K. Goergen et al., Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians, BMJ, vol.346, p.2360, 2013.

W. Huang, C. Muo, C. Lin, J. , Y. et al., Paediatric head CT scan and subsequent risk of malignancy and benign brain tumour: a nation-wide population-based cohort study, Br J Cancer, vol.110, issue.9, pp.2354-60, 2014.

N. Journy, D. Laurier, and M. Bernier, Comment on: Are the studies on cancer risk from CT scans biased by indication? Elements of answer from a large-scale cohort study in France, Br J Cancer, vol.112, issue.11, pp.1843-1847, 2015.

L. Krille, S. Dreger, R. Schindel, T. Albrecht, M. Asmussen et al., Risk of cancer incidence before the age of 15 years after exposure to ionising radiation from computed tomography: results from a German cohort study, Radiat Environ Biophys, vol.54, issue.1, pp.1-12, 2015.

G. Dournes, D. Grodzki, J. Macey, P. Girodet, M. Fayon et al., Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T. Radiology, vol.276, pp.258-65, 2015.

G. Dournes, F. Menut, J. Macey, M. Fayon, J. Chateil et al., Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution, Eur Radiol, vol.26, issue.11, pp.3811-3831, 2016.

M. J. Welsh and A. E. Smith, Cystic fibrosis. Sci Am, vol.273, pp.52-61, 1995.

R. Busch, On the history of cystic fibrosis, Acta Univ Carol [Med] (Praha), vol.36, issue.1-4, pp.13-18, 1990.

S. Farber, Pancreatic Insufficiency and the Celiac Syndrome, N Engl J Med, vol.229, issue.18, pp.682-689, 1943.

D. H. Andersen and R. G. Hodges, Celiac syndrome; genetics of cystic fibrosis of the pancreas, with a consideration of etiology, Am J Dis Child, vol.72, pp.62-80, 1911.

D. Sant'agnese, P. Darling, R. C. Perara, G. A. Shea, and E. , Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas, AMA Am J Dis Child, vol.86, issue.5, p.619, 1953.

L. E. Gibson and R. E. Cooke, A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis, Pediatrics, vol.23, issue.3, pp.545-554, 1959.

M. Knowles, J. Gatzy, and R. Boucher, Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis, N Engl J Med, vol.305, issue.25, pp.1489-95, 1981.

P. M. Quinton, Suggestion of an abnormal anion exchange mechanism in sweat glands of cystic fibrosis patients, Pediatr Res, vol.16, issue.7, pp.533-540, 1982.

P. M. Quinton, Chloride impermeability in cystic fibrosis, Nature, vol.301, issue.5899, pp.421-423, 1983.

M. J. Welsh, Single apical membrane anion channels in primary cultures of canine tracheal epithelium, Pflugers Arch, vol.407, issue.2, pp.116-122, 1986.

M. A. Gray, J. R. Greenwell, and B. E. Argent, Secretin-regulated chloride channel on the apical plasma membrane of pancreatic duct cells, J Membr Biol, vol.105, issue.2, pp.131-173, 1988.

L. C. Tsui, M. Buchwald, D. Barker, J. C. Braman, R. Knowlton et al., Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker, Science, vol.230, issue.4729, pp.1054-1061, 1985.

B. Kerem, J. M. Rommens, J. A. Buchanan, D. Markiewicz, T. K. Cox et al., Identification of the cystic fibrosis gene: genetic analysis. Science, vol.245, pp.1073-80, 1989.

J. R. Riordan, J. M. Rommens, B. Kerem, N. Alon, R. Rozmahel et al., Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science, vol.245, pp.1066-73, 1989.

J. M. Rommens, M. C. Iannuzzi, B. Kerem, M. L. Drumm, G. Melmer et al., Identification of the cystic fibrosis gene: chromosome walking and jumping, Science, vol.245, issue.4922, pp.1059-65, 1989.

M. P. Anderson, R. J. Gregory, S. Thompson, D. W. Souza, S. Paul et al., Demonstration that CFTR is a chloride channel by alteration of its anion selectivity, Science, vol.12, issue.5016, pp.202-207, 1991.

G. Bellon and . Mucoviscidose, Orphanet, 2006.

. Inserm and . Mucoviscidose,

A. Serohijos, T. Heged?s, A. A. Aleksandrov, L. He, L. Cui et al., Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function, Proc Natl Acad Sci, vol.105, issue.9, pp.3256-61, 2008.

D. N. Sheppard and M. J. Welsh, Structure and function of the CFTR chloride channel, Physiol Rev, vol.79, issue.1, pp.23-45, 1999.

K. J. Desmond, W. F. Schwenk, E. Thomas, P. H. Beaudry, and A. L. Coates, Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis, J Pediatr, vol.103, issue.4, pp.538-580, 1983.

C. Conrad, J. Lymp, V. Thompson, C. Dunn, Z. Davies et al., Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.14, issue.2, pp.219-246, 2015.

A. Equi, I. M. Balfour-lynn, A. Bush, and M. Rosenthal, Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial, Lancet Lond Engl, vol.360, issue.9338, pp.978-84, 2002.

M. Abely, V. Jubin, K. Bessaci-kabouya, R. Chiron, S. Bui et al.,

, Rev Mal Respir, vol.32, issue.6, pp.557-65, 2015.

D. Bilton, G. Canny, S. Conway, S. Dumcius, L. Hjelte et al., Report from the EuroCareCF Working Group on outcome parameters in clinical trials, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.10, issue.2, pp.79-81, 2011.

C. Marguet and I. Durieu, HAS mucoviscidose -Protocole national de diagnostic et de soins pour une maladie rare, 2017.

Z. Van-lier, V. Godding, and P. Lebecque, Ivacaftor : le tournant ? Louvain Médical, 2012.

J. C. Davies, C. E. Wainwright, G. J. Canny, M. A. Chilvers, M. S. Howenstine et al., Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation, Am J Respir Crit Care Med, vol.187, issue.11, pp.1219-1244, 2013.

B. W. Ramsey, J. Davies, N. G. Mcelvaney, E. Tullis, S. C. Bell et al., A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation, N Engl J Med, vol.365, issue.18, pp.1663-72, 2011.

D. Boeck, K. Munck, A. Walker, S. Faro, A. Hiatt et al., Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.13, issue.6, pp.674-80, 2014.

P. A. Flume, T. G. Liou, D. S. Borowitz, H. Li, Y. K. Ordoñez et al., Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation, Chest, vol.142, issue.3, pp.718-742, 2012.

C. E. Wainwright, J. S. Elborn, B. W. Ramsey, G. Marigowda, X. Huang et al., LumacaftorIvacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR, N Engl J Med, vol.16, issue.3, pp.220-251, 2015.

J. L. Taylor-cousar, A. Munck, E. F. Mckone, C. K. Van-der-ent, A. Moeller et al., Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del, N Engl J Med, vol.377, issue.21, pp.2013-2036, 201723.

T. Kirby, Tezacaftor-ivacaftor is safe and efficacious in patients with cystic fibrosis with Phe508del mutations, Lancet Respir Med, vol.6, issue.1, pp.13-17, 2018.

S. M. Rowe, C. Daines, F. C. Ringshausen, E. Kerem, J. Wilson et al., Tezacaftor-Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis, N Engl J Med, vol.377, issue.21, pp.2024-2059, 201723.

C. Colombo, C. Fredella, M. C. Russo, N. Faelli, V. Motta et al., Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study, Pancreas, vol.38, issue.6, pp.693-702, 2009.

B. C. Trapnell, K. Maguiness, G. R. Graff, D. Boyd, K. Beckmann et al., Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.8, issue.6, pp.370-377, 2009.

K. L. Ode and A. Moran, New insights into cystic fibrosis-related diabetes in children, Lancet Diabetes Endocrinol, vol.1, issue.1, pp.52-60, 2013.

I. Sermet-gaudelus, L. Couderc, S. Vrielynck, J. Brouard, L. Weiss et al., National French guidelines for management of infants with cystic fibrosis, vol.21, pp.654-62, 2014.

E. Kerem, S. Conway, S. Elborn, and H. Heijerman, Standards of care for patients with cystic fibrosis: a European consensus, J Cyst Fibros, vol.4, issue.1, pp.7-26, 2005.

A. R. Smyth, S. C. Bell, S. Bojcin, M. Bryon, A. Duff et al., European Cystic Fibrosis Society Standards of Care: Best Practice guidelines, J Cyst Fibros, vol.13, pp.23-42, 2014.

D. Borowitz, K. A. Robinson, M. Rosenfeld, S. D. Davis, K. A. Sabadosa et al., Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis, J Pediatr, vol.155, issue.6, pp.73-93, 2009.

. Has and . Mucoviscidose, Protocole national de diagnostiv et de soins pour une maladie rare, 2006.

H. Tiddens, Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis, Paediatr Respir Rev, vol.7, issue.3, pp.202-210, 2006.

S. Terheggen-lagro, N. Truijens, N. Van-poppel, V. Gulmans, J. Van-der-laag et al., Correlation of six different cystic fibrosis chest radiograph scoring systems with clinical parameters, Pediatr Pulmonol, vol.35, issue.6, pp.441-446, 2003.

D. Brasfield, G. Hicks, S. Soong, J. Peters, and R. Tiller, Evaluation of scoring system of the chest radiograph in cystic fibrosis: a collaborative study, AJR Am J Roentgenol, vol.134, issue.6, pp.1195-1203, 1980.

D. M. Hansell, A. A. Bankier, H. Macmahon, T. C. Mcloud, N. L. Müller et al., Fleischner Society: Glossary of Terms for Thoracic Imaging, Radiology, vol.246, issue.3, pp.697-722, 2008.

F. R. Long, R. S. Williams, and R. G. Castile, Structural airway abnormalities in infants and young children with cystic fibrosis, J Pediatr, vol.144, issue.2, pp.154-61, 2004.

A. S. Brody, H. Sucharew, J. D. Campbell, S. P. Millard, P. L. Molina et al., Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis, Am J Respir Crit Care Med, vol.172, issue.9, pp.1128-1160, 2005.

L. A. Tepper, E. Utens, D. Caudri, A. C. Bos, K. Gonzalez-graniel et al., Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis, Eur Respir J, vol.42, issue.2, pp.371-380, 2013.

M. Loeve, W. Hop, M. De-bruijne, P. Van-hal, P. Robinson et al., Chest Computed Tomography Scores Are Predictive of Survival in Patients with Cystic Fibrosis Awaiting Lung Transplantation, Am J Respir Crit Care Med, vol.185, issue.10, pp.1096-103, 2012.

T. M. Martínez, C. J. Llapur, T. H. Williams, C. Coates, R. Gunderman et al., HighResolution Computed Tomography Imaging of Airway Disease in Infants with Cystic Fibrosis, Am J Respir Crit Care Med, vol.172, issue.9, pp.1133-1141, 2005.

D. Rawlings, D. Tennant, and J. Furness, Progressive damage on high-resolution computed tomography, Eur Respir J, vol.24, issue.6, pp.1071-1072, 2004.

H. Tiddens, Detecting early structural lung damage in cystic fibrosis, Pediatr Pulmonol, vol.34, issue.3, pp.228-259, 2002.

T. H. Helbich, G. Heinz-peer, D. Fleischmann, C. Wojnarowski, P. Wunderbaldinger et al., Evolution of CT findings in patients with cystic fibrosis, AJR Am J Roentgenol, vol.173, issue.1, pp.81-89, 1999.

A. S. Brody, J. S. Klein, P. L. Molina, J. Quan, J. A. Bean et al., High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests, J Pediatr, vol.145, issue.1, pp.32-40, 2004.

I. Nathanson, K. Conboy, S. Murphy, E. Afshani, and J. P. Kuhn, Ultrafast computerized tomography of the chest in cystic fibrosis: a new scoring system, Pediatr Pulmonol, vol.11, issue.1, pp.81-87, 1991.

A. S. Brody, Cystic Fibrosis: When Should High-resolution Computed Tomography of the Chest Be Obtained? PEDIATRICS, vol.101, pp.1071-1071, 1998.

F. Cademartiri, G. Luccichenti, A. A. Palumbo, E. Maffei, G. Pisi et al., Predictive Value of Chest CT in Patients with Cystic Fibrosis: A Single-Center 10-Year Experience, Am J Roentgenol, vol.190, issue.6, pp.1475-80, 2008.

M. Bhalla, N. Turcios, V. Aponte, M. Jenkins, B. S. Leitman et al., Cystic fibrosis: scoring system with thin-section CT, Radiology, vol.179, issue.3, pp.783-791, 1991.

T. H. Helbich, G. Heinz-peer, I. Eichler, P. Wunderbaldinger, M. Götz et al., Cystic fibrosis: CT assessment of lung involvement in children and adults, Radiology, vol.213, issue.2, pp.537-581, 1999.

A. S. Brody, M. R. Kosorok, Z. Li, L. S. Broderick, J. L. Foster et al., Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis, J Thorac Imaging, vol.21, issue.1, pp.14-21, 2006.

M. Maffessanti, M. Candusso, F. Brizzi, and F. Piovesana, Cystic fibrosis in children: HRCT findings and distribution of disease, J Thorac Imaging, vol.11, issue.1, pp.27-38, 1996.

A. Oikonomou, J. Tsanakas, E. Hatziagorou, F. Kirvassilis, S. Efremidis et al., High resolution computed tomography of the chest in cystic fibrosis (CF): is simplification of scoring systems feasible?, Eur Radiol, vol.18, issue.3, pp.538-585, 2008.

L. Krestinina, D. L. Preston, F. G. Davis, S. Epifanova, E. Ostroumova et al., Leukemia incidence among people exposed to chronic radiation from the contaminated Techa River, Radiat Environ Biophys, vol.49, issue.2, pp.195-201, 1953.

L. Y. Krestinina, F. Davis, E. Ostroumova, S. Epifanova, M. Degteva et al., Solid cancer incidence and low-dose-rate radiation exposures in the Techa River cohort, Int J Epidemiol, vol.36, issue.5, pp.1038-1084, 2007.

M. M. Kossenko, M. O. Degteva, O. V. Vyushkova, D. L. Preston, K. Mabuchi et al., Issues in the comparison of risk estimates for the population in the Techa River region and atomic bomb survivors, Radiat Res, vol.148, issue.1, pp.54-63, 1997.

O. J. O'connell, S. Mcwilliams, A. Mcgarrigle, O. J. O'connor, F. Shanahan et al., Radiologic Imaging in Cystic Fibrosis, Chest, vol.141, issue.6, pp.1575-83, 2012.

H. Baysson, N. Journy, T. Roué, H. Ducou-lepointe, C. Etard et al., Exposition à la scanographie dans l'enfance et risque de cancer à long terme. Une synthèse des études épidémiologiques récentes, Bull Cancer, vol.103, issue.2, pp.190-198, 2016.

A. B. De-gonzalez, R. E. Curtis, S. F. Kry, E. Gilbert, S. Lamart et al., Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries, Lancet Oncol, vol.12, issue.4, pp.353-60, 2011.

M. S. Linet, . Kim-k-pyo, and P. Rajaraman, Children's exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations, Pediatr Radiol, vol.39, issue.S1, pp.4-26, 2009.
DOI : 10.1007/s00247-008-1026-3

URL : http://europepmc.org/articles/pmc2814780?pdf=render

H. Baysson, C. Etard, H. J. Brisse, and M. Bernier, Expositions radiologiques à visée diagnostique pendant l'enfance et risque de cancer : bilan des connaissances et perspectives. Arch Pédiatrie, vol.19, pp.64-73, 2012.
DOI : 10.1016/j.arcped.2011.10.023

M. Bosch-de-basea, M. S. Pearce, A. Kesminiene, M. Bernier, J. Dabin et al., EPI-CT: design, challenges and epidemiological methods of an international study on cancer risk after paediatric and young adult CT, J Radiol Prot Off J Soc Radiol Prot, vol.35, issue.3, pp.611-639, 2015.

A. Oleko, F. Betsou, H. Sarter, C. Gerdil, I. Desbois et al., A Pilot Study of the ELFE Longitudinal Cohort: Feasibility and Preliminary Evaluation of Biological Collection, Biopreservation Biobanking, vol.9, issue.3, pp.223-230, 2011.

L. Dosseur, P. Sannier, and N. , Conseil des enseignants de radiologie de France (CERF), Direction générale de la sûreté nucléaire et de la radioprotection (DGSNR), et al. [Guidelines for diagnostic imaging in children and responsibility of the referring physician, Agence nationale d'accréditation et d'évaluation de la santé (Anaes), vol.13, pp.795-802, 2006.

M. Puderbach, C. Hintze, S. Ley, M. Eichinger, H. Kauczor et al., MR imaging of the chest: A practical approach at 1.5T, Eur J Radiol, vol.64, issue.3, pp.345-55, 2007.

M. Eichinger, M. Puderbach, C. Fink, J. Gahr, S. Ley et al., Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis-initial results, Eur Radiol, vol.16, issue.10, pp.2147-52, 2006.

M. Eichinger, D. Optazaite, A. Kopp-schneider, C. Hintze, J. Biederer et al., Morphologic and functional scoring of cystic fibrosis lung disease using MRI, Eur J Radiol, vol.81, issue.6, pp.1321-1330, 2012.

C. Sileo, H. Corvol, P. Boelle, E. Blondiaux, A. Clement et al., HRCT and MRI of the lung in children with cystic fibrosis: Comparison of different scoring systems, J Cyst Fibros, vol.13, issue.2, pp.198-204, 2014.

G. Dournes, D. Grodzki, J. Macey, P. Girodet, M. Fayon et al., Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T. Radiology, vol.279, p.328, 2016.

C. E. Milla, F. Ratjen, G. Marigowda, F. Liu, D. Waltz et al., Lumacaftor/Ivacaftor in Patients Aged 6-11 Years with Cystic Fibrosis and Homozygous for F508del-CFTR, Am J Respir Crit Care Med, vol.195, issue.7, pp.912-932, 2017.

J. L. Taylor-cousar, M. Jain, T. L. Barto, T. Haddad, J. Atkinson et al., Lumacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease homozygous for F508del-CFTR, J Cyst Fibros, vol.17, issue.2, pp.228-263, 2018.

T. Guevara, M. Mccolley, and S. A. , The safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis. Expert Opin Drug Saf, vol.16, pp.1305-1316, 2017.

G. Dournes, P. Berger, J. Refait, J. Macey, S. Bui et al., Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis: MR Imaging of Airway Mucus Contrasts as a Tool for Diagnosis, Radiology, vol.285, issue.1, pp.261-270, 2017.

, Serment d'Hippocrate

, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je donnerai mes soins à l'indigent et à quiconque me les demandera. Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses

, Conseil de l'ordre des médecins, 2012.